DK144083B - PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF PIGS - Google Patents

PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF PIGS Download PDF

Info

Publication number
DK144083B
DK144083B DK265771AA DK265771A DK144083B DK 144083 B DK144083 B DK 144083B DK 265771A A DK265771A A DK 265771AA DK 265771 A DK265771 A DK 265771A DK 144083 B DK144083 B DK 144083B
Authority
DK
Denmark
Prior art keywords
endotoxins
pigs
endotoxin
coli
feed
Prior art date
Application number
DK265771AA
Other languages
Danish (da)
Other versions
DK144083C (en
Inventor
I R Hill
R Kenworthy
P Porter
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of DK144083B publication Critical patent/DK144083B/en
Application granted granted Critical
Publication of DK144083C publication Critical patent/DK144083C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

(19) DANMARK(19) DENMARK

|j| (12) FREMLÆGGELSESSKRIFT ud m083B| J | (12) SUBMISSION WRITING out m083B

DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM

(21) Ansøgning nr. 2657/71 (51) IntCI.3 A 61 K 39/02 (22) Indleveringsdag 1 . jun. 1971 // A 23 K 1/18 (24) Løbedag 1. jun. 1971 (41) Aim. tilgængelig 4. dec. 1971 (44) Fremlagt 7· dec. 1981 (86) International ansøgning nr.(21) Application No. 2657/71 (51) IntCI.3 A 61 K 39/02 (22) Filing Day 1. June 1971 // A 23 K 1/18 (24) Race day 1 Jun. 1971 (41) Aim. available Dec. 4; 1971 (44) Posted 7 Dec. 1981 (86) International application no.

(86) International indleveringsdag (85) Videreførelsesdag -(62) Stamansøgning nr. -(86) International filing day (85) Continuation day - (62) Master application no. -

(30) Prioritet 3. jun. 1970 , 26746/70, GB(30) Priority 3 Jun. 1970, 26746/70, GB

(71) Ansøger UNILEVER N.V., Rotterdam, NL.(71) Applicant UNILEVER N.V., Rotterdam, NL.

(72) Opfinder jan Roland Hill, GB: Raymond Kenworthy, GB: Philip(72) Inventor Jan Roland Hill, GB: Raymond Kenworthy, GB: Philip

Porter, GB.Porter, GB.

(74) Fuldmægtig ingeniørfirmaet Budde, Schou & Co.(74) The engineering firm Budde, Schou & Co.

(54) Fremgangsmåde til fremstilling af et middel til forhindring af gastro-intestinale forstyrrelser hos svin.(54) Process for the preparation of an agent for the prevention of gastrointestinal disorders in pigs.

Den foreliggende opfindelse angår en fremgangsmåde til fremstilling af et middel til forhindring af gastro-intestinale forstyrrelser hos svin, og denne fremgangsmåde er af den art, hvor man dyrker pathogene svinetarminficerende bakterier, skiller bakte-OQ rierne fra kulturen og dræber de fraskilte bakterier på en sådan 2 måde, at endotoxiner frigøres fra bakteriernes celler.The present invention relates to a method of preparing a means for preventing gastrointestinal disorders in pigs, and this method is of the kind in which pathogenic porcine gut-infecting bacteria are cultivated, separating the bacterial OQs from the culture and killing the separated bacteria on a such a way that endotoxins are released from the cells of the bacteria.

3 Gastro--intenstinale forstyrrelser hos svin stammer ofte ^ fra tilstedeværelsen i tarmen af én eller flere patogene stammer3 Gastro - intestinal disorders in pigs often arise from the presence in the intestine of one or more pathogenic strains

«J'J

[— af bakterien Escherichia coli, især stammer af følgende serotyper: * 3 2 144083[- of the bacterium Escherichia coli, in particular strains of the following serotypes: * 3 2 144083

Weybridqe-klassificering International serotype- klassificering_ G7 08 : K87 (B) K88a,b(L)Weybridqe classification International serotype classification_ G7 08: K87 (B) K88a, b (L)

E65 045 : KE65 045: K

E57 0138 : K81 (B) E4 0139 : K82 (B) E68II 0141 : K85a,b->K85a,c(B) G1253 0147 : K89 (B) K88a,c(L) 'Abbotstown' 0149 ; K91 K88a,e(L) Når svins omgivelser eller kost ændres, f.eks. når de flyttes eller vænnes fra, efterlader ændringen i vilkårene svinets system i en tilstand, der er gunstig for formeringen af de pathogene E. coli-stammer, og de gastro-intestinale forstyrrelser, som kan være resultatet deraf forringer dyrets almene helbredstilstand og vægtforøgelse, ofte med dødelig udgang.E57 0138: K81 (B) E4 0139: K82 (B) E68II 0141: K85a, b-> K85a, c (B) G1253 0147: K89 (B) K88a, c (L) 'Abbotstown' 0149; K91 K88a, e (L) When the pig's environment or diet changes, e.g. when moved or weaned, the change in conditions leaves the pig's system in a state favorable to the propagation of the pathogenic E. coli strains, and the gastrointestinal disorders that may result from it impair the general health and weight gain of the animal, often with fatal outcome.

Den foreliggende opfindelse er baseret på den erkendelse, at svinetarmen kan stimuleres til at danne antistoffer mod allerede tilstedeværende pathogene E. coli-stammer ved, at der i tarmen (og altså ikke i blodstrømmen som ved injektion) indføres endotoxinerne af én eller flere af de ovenfor nævnte E. coli-serotyper, praktisk taget fri for levende E. coli-organis-mer.The present invention is based on the recognition that the porcine gut can be stimulated to produce antibodies against pathogenic E. coli strains already present by introducing into the gut (and thus not in the blood stream as by injection) the endotoxins of one or more of the above E. coli serotypes, practically free of living E. coli organisms.

Fremgangsmåden ifølge opfindelsen, der er af den allerede angivne art, er i overensstemmelse med det ovenfor anførte ejendommelige ved, at man fremstiller endotoxiner fra én eller flere af de pathogene E. coli-serotyper 08, 045, 0138, 0139, 0141, 0147 og 0149, hvorefter de frigjorte endotoxiner blandes med sædvanlige foderbestanddele, fortrinsvis ved pH 5-6.The process according to the invention, which is of the kind already described, is in accordance with the above-mentioned property in that it produces endotoxins from one or more of the pathogenic E. coli serotypes 08, 045, 0138, 0139, 0141, 0147 and 0149, after which the released endotoxins are mixed with usual feed ingredients, preferably at pH 5-6.

Når det materiale, der skal indføres i svinetarmen, specificeres som "endotoxiner", er der ikke hermed ment, at der fra dette materiale skal være udelukket tilstedeværelsen af exotoxi-ner eller af det cellulære materiale, hvori endotoxinerne er indesluttet i den levende bakterie; meningen er blot, at endotoxinerne er af primær betydning for opnåelse af den ønskede immunologiske virkning, medens dette ikke er tilfældet for exotoxinerne og celleresterne. Imidlertid vil det i nogle tilfælde være hensigtsmæssigt at lade enten exotoxiner eller cellerester eller begge dele 3 U4083 forblive forbundet med endotoxinerne, for det første fordi man derved sparer sig besværet med at adskille dem, og for det andet, for at man får mulighed for at udnytte deres antigene evne.When the material to be introduced into the pig intestine is specified as "endotoxins", it is not intended to exclude the presence of exotoxins or of the cellular material in which the endotoxins are contained in the living bacterium; it is merely intended that the endotoxins are of primary importance in achieving the desired immunological effect, while this is not the case for the exotoxins and cell debris. However, in some cases it will be appropriate to allow either exotoxins or cell debris or both 3 U4083 to remain associated with the endotoxins, firstly, thereby saving you the trouble of separating them, and secondly, allowing you to utilize their antigenic ability.

Som allerede nævnt har indføring i tarmen ("indgiv-ning") af endotoxinerne af kun en enkelt af de ovenfor nævnte E. coli-serotyper nogen gunstig virkning, for så vidt som den nævnte serotypes evne til at gøre fortræd derved vil blive nedsat, men det er at foretrække at indgive endotoxinerne af alle serotyperne, og i overensstemmelse hermed er det ved fremgangsmåden ifølge opfindelsen særlig hensigtsmæssigt, at der i foderet inkorporeres endotoxiner fra alle de nævnte syv E. coli-serotyper. De endotoxiner, der skal indgives, kan op·’ nås ved dyrkning af hver serotype, hvoraf prøver kan fås fra Central Veterinary Laboratory, Ministry of Agriculture and Fischeries, New Haw, Weybridge, Surrey, UK, og når væksten af mikroorganismen og dermed dannelsen af endotoxiner er skredet frem i passende grad, dræbes de formeringsdygtige mikroorganismer og endotoxinerne frigøres, hvilket kan gøres ved kog” ning eller autoklavering. Hele de steriliserede kulturer, der hver indeholder exotoxiner og cellerester såvel som endotoxiner, kan derefter forenes og indgives, men i stedet for at sterilisere hele kulturerne er det at foretrække, at bakterierne fraskilles, således som det sker ved fremgangsmåden ifølge opfindelsen, hensigtsmæssigt ved centrifugering, og behandles i et lille rumfang af et vandigt medium, f.eks. vand eller saltopløsning, til dræbning af bakterierne og frigørelse af endotoxinerne.As already mentioned, introduction into the intestine ("administration") of the endotoxins of only one of the above E. coli serotypes has some beneficial effect insofar as the ability of the aforementioned serotype will thereby be impaired. but it is preferable to administer the endotoxins of all the serotypes, and accordingly, by the method of the invention, it is particularly convenient that endotoxins from all the seven E. coli serotypes mentioned are incorporated into the feed. The endotoxins to be administered can be obtained by culturing each serotype, samples of which can be obtained from the Central Veterinary Laboratory, Ministry of Agriculture and Fischeries, New Haw, Weybridge, Surrey, UK, and reaching the growth of the microorganism and thus its formation. of endotoxins has progressed appropriately, the reproductive microorganisms are killed and the endotoxins released, which can be done by boiling or autoclaving. The entire sterilized cultures, each containing exotoxins and cell debris as well as endotoxins, can then be combined and administered, but rather than sterilizing the entire cultures, it is preferable that the bacteria be separated, as is the case by the process of the invention, suitably by centrifugation. and treated in a small volume of an aqueous medium, e.g. water or saline solution, to kill the bacteria and release the endotoxins.

Den simpleste og mest økonomiske måde til dræbning af de fraskilte bakterier består i en opvarmning. Hvis opvarmningen er tilstrækkelig langvarig, f.eks. 1 time til 100°C, 20 minutter til 125°C, bliver det meste af endotoxinet befriet for at være forbundet med cellevæggene fra de dræbte bakterier og bliver frigjort i det medium, hvori opvarmningen udføres. De resterende bundne endotoxiner kan, som det er konstateret, bringes i opløsning ved behandling med et enzym såsom trypsin, lysozym, pepsin, lipase eller blandinger deraf. Resultaterne af typiske behandlingsmåder er sammenfattet i tabel I, der viser de rela- 4 144083 tive mængder (titeren) af endotoxiner, der er frigjort i vandet ved en indledende behandling til dræbning af bakterierne efterfulgt af en enzymbehandling til frigørelse af endotoxin, der er efterladt bundet til bakteriecellevæggene.The simplest and most economical way to kill the separated bacteria consists of heating. If the heating is sufficiently long-lasting, e.g. 1 hour to 100 ° C, 20 minutes to 125 ° C, most of the endotoxin is released to be associated with the cell walls of the killed bacteria and released in the medium in which the heating is performed. The residual bound endotoxins can, as it is found, be dissolved by treatment with an enzyme such as trypsin, lysozyme, pepsin, lipase or mixtures thereof. The typical treatment results are summarized in Table I, showing the relative amounts (titer) of endotoxins released in the water by an initial treatment to kill the bacteria followed by an enzyme treatment to release endotoxin left behind. bound to the bacterial cell walls.

5 U4D63 o ο t- ια5 U4D63 o ο t- ια

AA

tu ε ί> Ch I Ν Η ΟΟΟΟ οοtu ε ί> Ch I Ν Η ΟΟΟΟ οο

C φ Ο + m OJ OJ CM CM CVJ ODC φ Ο + m OJ OJ CM CM CVJ OD

Φ Ε Φ a η Η Η ΓΑ γΗ CMΦ Ε Φ a η Η Η ΓΑ γΗ CM

.ρ η >3 ω in ιη ιλ ια η Ρ -Ρ Η & Φ.ρ η> 3 ω in ιη ιλ ια η Ρ -Ρ Η & Φ

ι—Iι-I

bObO

c -η ε c •Η *Η _ Η Ε Ν Φ ΟΟΟΟ Ο Ο Ό >, Ο + α C0 ΟΙ ΟΙ 4- VO νο C tsl Φ t>3 CVJ Η Η Ά ΙΑ ΙΑc -η ε c • Η * Η _ Η Ε Ν Φ ΟΟΟΟ Ο Ό>, Ο + α C0 ΟΙ ΟΙ 4- VO νο C tsl Φ t> 3 CVJ Η Η Ά ΙΑ ΙΑ

Βίβ ^ Η LA ΙΑ ΟΙ CVJΒίβ ^ Η LA ΙΑ ΟΙ CVJ

,β Φ Η -Ρ Φ A Α m φ &ο ε β β Φ -Η _ Λ ^ -η C ra m οο ο οο C φ Cd a 00 VO 00 00 00 A-Hft+l>30JLniOJ cm oj, β Φ Η -Ρ Φ A Α m φ & ο ε β β Φ -Η _ Λ ^ -η C ra m οο ο οο C φ Cd a 00 VO 00 00 00 A-Hft + l> 30JLniOJ cm oj

$ ^ ri Ιμ i—I OJ H HH$ ^ ri Ιµ i — I OJ H HH

β Φ Η Aβ Φ Η A

Α -P id A cd H)i «) „ ^ > w o o o o φ cd co uo co cvj .p -p o, oi ia i OJ rA iΑ -P id A cd H) i «)„ ^> w o o o o φ cd co uo co cvj .p -p o, oi ia i OJ rA i

β A H i—I OJ Hβ A H i — I OJ H

O s HO s H

uu

bOABoa

•H• H

β φ β HAH ΟΟΟΟ ΟΟ W Ά CM CM CO -3- 00β φ β HAH ΟΟΟΟ ΟΟ W Ά CM CM CO -3- 00

C Ή & LO Η H OJ Ά CMC LO & LO Η H OJ Ά CM

•H CtJ Φ OJ LA LA i—f i—I• H CtJ Φ OJ LA LA i — f i — I

Η XI &Η XI &

O bOO bO

Η Α βΗ Α β

Φ OHΦ OH

a ό η ε β β Ό >» „ _ „ ^ Ρη φβΝ ΟΟΟΟ ΟΟa ό η ε β β Ό> »„ _ „^ Ρη φβΝ ΟΟΟΟ ΟΟ

cdO -3- co νο CM VOcdO -3- co νο CM VO

φ Α Μ VAOJlAVO ΙΑ LO Φ Α Φ >3 Η CM CM Ε hOA Η ω β Α S Ά g Β* c a A A Η „ β φ bO Φ ΟΟΟΟ ΟΟ Ο ΗΗ a CO Ά Ά VO -3" Ά ο ε β >3 ΟΙ ΙΑ ΙΑ in VAIA β idCi β Η (Μ ΟΙ οι οι id co a ε β Α Η Α β XI β ΟΟ ΟΟΟΟ ΟΟ Φ -pr^ ΟΙ 00 ΙΟ 4- -3" A" Φ Ο&ο ΓΑ CM LA Ά VAVO >3 Α Η ϋ Η ΟΙ Η β βφ Α Μ VAOJlAVO ΙΑ LO Φ Α Φ> 3 Η CM CM Ε hOA Η ω β Α S Ά g Β * ca AA Η “β φ bO Φ ΟΟΟΟ ΟΟ Ο a CO Ά Ά VO -3" Ά ο ε β> 3 ΟΙ ΙΑ ΙΑ in VAIA β idCi β Η (Μ ΟΙ οι οι οι id co a ε β Α Η Α β XI β ΟΟ ΟΟΟΟ ΟΟ Φ -pr ^ ΟΙ 00 ΙΟ 4- -3 "A" Φ & ο CM LA Ά VAVO > 3 Α Η ϋ Η ΟΙ Η β β

W Η bOW Η bO

Η Η — β ^ a β β &ο β ε η φ aΗ Η - β ^ a β β & ο β ε η φ a

Ci φ cd · ο ε βCi φ cd · ο ε β

Η bO β β Η CΗ bO β β Η C

,—1C 1—I ΙΑ Η Η Cd A, —1C 1 — I ΙΑ Η Η Cd A

AO · * A *. Ε A AAO · * A *. Ε A A

c a c β a η ο β cm φ cd Η Η O LA Α Α Φ Ε Ε Φ **>IA -=J· h Φ ra id Φ bO a AH ο ο φ > h A ho β ω Φ CM CM H TS. Φ « AO o bOA I ββΟ >β fil· -2 c A H H O ao Η cd ΙΑ ω Η SB m O LA E t> Ηc a c β a η ο β cm φ cd Η O LA Α Α Φ Ε Ε **> IA - = J · h Φ ra id Φ bO a AH ο φ> h A ho β ω Φ CM CM H TS. Φ «AO o bOA I ββΟ> β fil · -2 c A H H O ao Η cd ΙΑ ω Η SB m O LA E t> Η

Cm o o cd Ε r Α β aa o o β ε a ao ra φ ά iBC O LA Α Φ M0 - > irfCm o o cd Ε r Α β aa o o β ε a ao ra φ ά iBC O LA Α Φ M0 -> irf

β^ o oj η σ\ > k >Rβ ^ o oj η σ \> k> R

p HH pw a LAp HH pw and LA

6 144083 I praksis sker indgivningen af endotoxinerne til svinet selvfølgelig gennem munden, enten simpelt hen ved tvunget indgivning af sterilt kulturmateriale eller med drikkevandet eller som en bestanddel af et svinefoder, hensigtsmæssigt et foder, der indeholder det protein, den carbon-hydratkilde, f.eks. korn, og de mineraler og mineralstoffer, der er essentielle bestanddele for svinekost.In practice, of course, the administration of the endotoxins to the pig occurs by mouth, either simply by forced administration of sterile culture material or with the drinking water or as a constituent of a pig feed, suitably a feed containing the protein, the carbohydrate source, f. eg. cereals, and the minerals and minerals that are essential constituents of pig food.

Det er konstateret, at sådanne svinefoderbestanddele som sildemel, gær, hvedemel, knust havre, malet byg og skummetmælkspulver er tilbøjelige til at binde E. coli-endotoxiner til sig ved pH-værdier på 5,9 og derover, således som det fremgår af tabel II.Such pig feed constituents such as herring flour, yeast, wheat flour, crushed oats, ground barley and skimmed milk powder have been found to bind to E. coli endotoxins at pH values of 5.9 and above, as shown in Table II.

Tabel IITable II

Titer af bundet endotoxin pr. enhedsvægt bestanddel ved pH =Titer of bound endotoxin per unit weight component at pH =

Kostbestanddel 5,3 5,9 6,3 6,8 7,2Dietary component 5.3 5.9 6.3 6.8 7.2

Hvedemel 0 480 480 480 560Wheat flour 0 480 480 480 560

Havreskrå 000 320 560Oatmeal 000 320 560

Malet byg 0 0 320 320 480Painted barley 0 0 320 320 480

Sildemel 0 480 480 480 560 Gær 0 320 480 480 560 tHerring flour 0 480 480 480 560 yeast 0 320 480 480 560 t

Skummetmælkspulver j 0 320 480 480 560Skimmed milk powder j 0 320 480 480 560

Det er også konstateret, at proteolytiske enzymer som f.eks. trypsin er i stand til at frigøre det på denne måde bundne endotoxin. Således vil trypsin ved en pH-værdi på 7,2 frigøre ca. halvdelen af det ovenfor bundne endotoxin-indhold i gær og skummetmælkspulver.It has also been found that proteolytic enzymes such as trypsin is capable of releasing the endotoxin bound in this way. Thus, at a pH of 7.2, trypsin will release approx. half of the above bound endotoxin content in yeast and skimmed milk powder.

Desuden er det konstateret, at E. coli-endotoxiner udfældes fra vandige systemer ved pH-værdier på under 5, som det fremgår af tabel III.In addition, E. coli endotoxins have been found to precipitate from aqueous systems at pH values below 5 as shown in Table III.

144083 7144083 7

Tabel IIITable III

pH- Titer for endotoxin i standardværdi opl. efter indstilling på den angivne pH-vardi_ 7.0 320 6.5 320 6.0 320 5.5 320 5.0 320 4.5 160 4.0 80 3,2 40 2.5 40pH Titer for standard value endotoxin after adjusting to the specified pH value 7.0 320 6.5 320 6.0 320 5.5 320 5.0 320 4.5 160 4.0 80 3.2 40 2.5 40

Det er hensigtsmæssigt at inkorporere endotoxinerne i et foder ved, at man først fremstiller en for-blanding af endotoxinerne med en af foderbestanddelene (hensigtsmæssigt skummetmælk) og vand, hvorefter denne for-blanding blandes med de øvrige af foderets bestanddele. Ved anvendelse af denne metode er det ønskeligt, med henblik til de i tabellerne II og III anførte resultater, at indstille for-blandingens pH-værdi på 5-6 til sikring af, at i det mindste en del af indholdet af endotoxiner i foderet straks efter synkningen bliver stillet til rådighed for stimulering af immunsystemet i svinets tarme. Ved fremgangsmåden ifølge opfindelsen er det således hensigtsmæssigt, at der fremstilles en for-blanding af endotoxinerne med ét eller flere næringsstoffer ved en pH-værdi på 5-6, og at denne for-blanding derefter blandes med de øvrige næringsstoffer.It is convenient to incorporate the endotoxins into a feed by first preparing a premix of the endotoxins with one of the feed ingredients (suitably skim milk) and water, after which this premix is mixed with the other ingredients of the feed. Using this method, it is desirable, for the results set forth in Tables II and III, to adjust the pH of the pre-mix to 5-6 to ensure that at least part of the content of endotoxins in the feed immediately after the sinking is made available for stimulation of the immune system in the intestine of the pig. Thus, in the process of the invention, it is convenient that a premix of the endotoxins be prepared with one or more nutrients at a pH of 5-6 and that this premix is then mixed with the other nutrients.

Opfindelsen er især af betydning til forbedring af infektionsresistensen hos svin på afvænningsstadiet, hvor de er særlig udsatte for stress. Ved indgivning af endotoxinmateria-let før svinet vænnes fra, begyndende f.eks., når det er 4-10 døgn gammelt, og fortsættende indtil afvænningen, kan svinetarmen stimuleres til at danne passende antistoffer, således at der, på det tidspunkt, hvor grisen tages fra soen, er en tilstrækkelig stor antistofcirkulation i tarmen til at dække enhver 8 144083 E. coli-formering eller i det mindste at formindske alvorligheden af enhver sygdomstilstand fremkaldt deraf. Endotoxin-ma-terialet kan til dette formål inkorporeres i et såkaldt "stiv-sygefoder", dvs. et foder, der er specielt sammensat til at opfylde næringskravene for svin på afvænningsstadiet. Foderet gives i dette tilfælde til grisene, idet man sørger for at forhindre soen i at æde det, almindeligvis ved kun at gøre det tilgængeligt gennem en smal åbning.The invention is particularly important for improving the infection resistance of pigs at the weaning stage, where they are particularly vulnerable to stress. By administering the endotoxin material before the pig is weaned, starting, for example, when it is 4-10 days old, and continuing until weaning, the pig intestine can be stimulated to form appropriate antibodies so that, at the time when the pig taken from the sow is a sufficiently large antibody circulation in the gut to cover any E. coli proliferation or at least to reduce the severity of any disease state caused by it. The endotoxin material can for this purpose be incorporated into a so-called "rigid" diet, ie. a feed specially formulated to meet the nutritional requirements for pigs at the weaning stage. In this case, the feed is given to the pigs, taking care to prevent the sow from eating it, usually by making it available only through a narrow opening.

Minimumsdoserne ligger i området 1-5 enheder (angående målingen af en enhed, se de følgende eksempler) af endotoxiner-ne af hver E. coli-serotype pr. svin pr. dag, men det er iagttaget, at svin, der fik 1000 gange denne mængde, ikke viste nogen dårlige virkninger. En meget velegnet mængde til inkor- 4 5 porering i et svinefoder er 10 -10 enheder af endotoxinerne af hver serotype pr. kg foder, og det således ved fremgangsmåden ifølge opfindelsen særlig hensigtsmæssigt, at endotoxinerne 4 5 af hver serotype E. coli inkorporeres i en mængde på 10 -10 hæmagglutinationsenheder pr. kg. foder.The minimum doses are in the range 1-5 units (regarding the measurement of a unit, see the following examples) of the endotoxins of each E. coli serotype per pigs per day, but it has been observed that pigs given 1000 times this amount showed no ill effects. A very suitable amount for incorporation into a pig feed is 10 to 10 units of the endotoxins of each serotype per day. Thus, in the process of the invention, it is particularly convenient for the endotoxins 45 of each E. coli serotype to be incorporated in an amount of 10 to 10 haemagglutination units per ml. kg. feed.

De følgende eksempler skal tjene til nærmere illustrering af fremgangsmåden ifølge opfindelsen.The following examples are intended to further illustrate the process of the invention.

Eksempel 1.Example 1.

Fremstilling og isolering af endotoxinerPreparation and Isolation of Endotoxins

Der fremstilles endotoxiner fra hver af de ovenfor omtalte syv E. coli-serotyper, idet der generelt følges den metode, der er angivet af Westphal, Luderitz og Bister (1952) i Z. Natur. Forsch. 7, 148.Endotoxins are prepared from each of the seven E. coli serotypes mentioned above, generally following the method set forth by Westphal, Luderitz and Bister (1952) in Z. Nature. Forsch. 7, 148.

Et frysetørret kultur af E. coli rekonstitueres i pep-ton-vand og inkuberes ved 37°C i 6 timer. Efter passende vækst kontrolleres kulturen for renhed på en vasket fåreblod/agar-pla-de, hvorefter den anvendes til podning af skråkulturer af næringsagar (Oxoid) i Roux-kolber. Kulturen dyrkes ved 37°C natten over, hvorefter bakterierne høstes i sterilt destilleret vand.A freeze-dried culture of E. coli is reconstituted in pep-ton water and incubated at 37 ° C for 6 hours. After appropriate growth, the culture of purity is checked on a washed sheep blood / agar plate and then used for grafting nutrient agar (Oxoid) slabs in Roux flasks. The culture is grown at 37 ° C overnight, after which the bacteria are harvested in sterile distilled water.

Den opnåede bakteriesuspension fordeles aseptisk i Universal--flasker på 30 ml og centrifugeres med 4000 rpm i 10 minutter.The bacterial suspension obtained is aseptically distributed in Universal bottles of 30 ml and centrifuged at 4000 rpm for 10 minutes.

Den overliggende væske fjernes, og den tilbageværende kage af 9 144083 bakterier resuspenderes i 4 ml sterilt destilleret vand og frysetørres.The overlying liquid is removed and the remaining cake of bacteria is resuspended in 4 ml of sterile distilled water and lyophilized.

Til isolering af endotoxinerne suspenderes 0,5 g frysetørret E. coli i 5 ml 0,15 M NaCl, og 10 ml 90%'s vandig phenol tilsættes som lyseringsmiddel. Blandingen opvarmes til 68°C i 30 minutter under kontinuert omrøring, hvorefter den centrifugeres ved 4000 rpm til sammenpakning af celleresterne.To isolate the endotoxins, 0.5 g of freeze-dried E. coli is suspended in 5 ml of 0.15 M NaCl, and 10 ml of 90% aqueous phenol is added as a lysing agent. The mixture is heated to 68 ° C for 30 minutes with continuous stirring, then centrifuged at 4000 rpm to compact the cell debris.

Den vandige fase fjernes og køles til 4°C, hvorpå den langsomt tilsættes 10 rumfang iskold ethanol. Det herved fremkomne bundfald genopløses i vand, og nucleinsyrer udfældes fra opløsningen ved tilsætning af 2 rumfang ethanol og fjernes. Fra den tilbageblivende opløsning udfældes endotoxinerne ved tilsætning af yderligere 8 rumfang ethanol, hvorpå de fraskilles ved centrifugering, vaskes med iskold ethanol og genopløses i 0,15 M NaCl.The aqueous phase is removed and cooled to 4 ° C, then slowly added 10 volumes of ice-cold ethanol. The resulting precipitate is redissolved in water and nucleic acids are precipitated from the solution by the addition of 2 volumes of ethanol and removed. From the residual solution, the endotoxins are precipitated by the addition of an additional 8 volumes of ethanol, which are separated by centrifugation, washed with ice-cold ethanol and redissolved in 0.15 M NaCl.

Denne opløsning af endotoxiner vil der i det følgende blive henvist til som Reagens 1.This solution of endotoxins will hereinafter be referred to as Reagent 1.

EE£¥CiQ2_å£_§SdQtQ2iner a. Fremstilling af antiserumEE £ ¥ CiQ2_å £ _§SdQtQ2iner a. Preparation of antiserum

Specifikke hyperimmune sera ("antisera") fremstilles i hvide New Zealand-kaniner mod vaskede, varmedræbte (100°C, 21/2 time) organismer af hver af E. coli-serotyperne.Specific hyperimmune sera ("antisera") are produced in white New Zealand rabbits against washed, heat killed (100 ° C, 21/2 hours) organisms of each of the E. coli serotypes.

Derefter fremstilles suspensioner af de varmedræbte or- q ganismer i 0,15 M NaCl (ca. 3 x 10 organismer pr. ml), og disse suspensioner injiceres intravenøst. Immuniseringsskemaet begynder ved et injektionsrumfang på 0,1 ml og fortsættes hver 4. dag med fordobling af rumfangene til 1,6 ml. Kaninerne tappes for blod 10 dage efter afslutning af immuniseringsskemaet, og det opnåede blod centrifugeres, idet det øverste lag af hype-rimmun-serum samles. Dette antiserum vil i det følgende blive betegnet som Reagens 2.Subsequently, suspensions of the heat-killed organisms are prepared in 0.15 M NaCl (about 3 x 10 organisms per ml) and these suspensions are injected intravenously. The immunization schedule begins at an injection volume of 0.1 ml and is continued every 4 days, doubling the volumes to 1.6 ml. The rabbits are drawn for blood 10 days after completion of the immunization schedule, and the blood obtained is centrifuged, collecting the top layer of hype immune serum. This antiserum will hereinafter be referred to as Reagent 2.

b. Måling af antistof (anti-endotoxin)-aktiviteten i antiserum Fåreerythrocyter sensibiliseres ved behandling af en 5%'s suspension af vaskede sammenpakkede celler med et lige så stort 10 144083 rumfang aÆ endotoxin-opløsningen Reagens 1 ved 37°C i 30 minutter, hvorefter de sensibiliserede celler fraskilles ved centrifugering, vaskes fri for overskud af endotoxiner og gensuspenderes i 0,15 M NaCl til dannelse af en 2,5%'s suspension af endotoxin-sensibiliserede fåreerythrocyter. Denne suspension vil i det følgende blive betegnet som Reagens 3.b. Measurement of antibody (anti-endotoxin) activity in antiserum Sheep erythrocytes are sensitized by treatment of a 5% suspension of washed packed cells with an equal volume of endotoxin solution Reagent 1 at 37 ° C for 30 minutes. , after which the sensitized cells are separated by centrifugation, washed free of excess endotoxins and resuspended in 0.15 M NaCl to form a 2.5% suspension of endotoxin-sensitized sheep erythrocytes. This suspension will hereinafter be referred to as Reagent 3.

Reagenset 2 (antiserummet) fortyndes serievis med 0,15 M NaCl til opnåelse af en række opløsninger med lige stort rumfang (1 vol) og med en antistofkoncentration på 1/5, 1/10, 1/20, „ _i 1/40.... 1/(5 x 2 ) af Reagens 2's koncentration, og til hver af disse opløsninger sættes 1/5 rumfang af Reagens 3. I de stærkere antiserum-opløsninger, men ikke i de svagere sker der en hæmagglutinering, og slutpunktet for titreringen (udført ved 4°C) tages som den opløsning, hvori der lige netop sker en hæmaggluti-nering. Ved en typisk metode kan dette slutpunkt være ved den tolvte opløsning, dvs. den opløsning, som har en antistofkoncen-tration på 1/(5 x 2^"*") af Reagens 2's koncentration. Reagens 2 siges da at have en antiserum-titer på 5 x 2^(= 10.240) .Reagent 2 (antiserum) is serially diluted with 0.15 M NaCl to give a series of solutions of equal volume (1 vol) and with an antibody concentration of 1/5, 1/10, 1/20, 1/1. ... 1 / (5 x 2) of Reagent 2's concentration, and to each of these solutions is added 1/5 volume of Reagent 3. In the stronger antiserum solutions, but not in the weaker ones, hemagglutination occurs and the end point of the titration (carried out at 4 ° C) is taken as the solution in which just a hemagglutination takes place. In a typical method, this end point may be at the twelfth solution, i.e. the solution having an antibody concentration of 1 / (5 x 2 3 ") of Reagent 2's concentration. Reagent 2 is then said to have an antiserum titer of 5 x 2 ^ (= 10,240).

c. Måling af koncentrationen af endotoxiner i en opløsning af ukendt koncentration_c. Measuring the concentration of endotoxins in a solution of unknown concentration_

Den opløsning (Y), der skal måles, fortyndes seriemæssigt med 0,15 M NaCl til opnåelse af en række opløsninger med lige stort rumfang (3 vol) og med endotoxin-koncentrationer på 1/3, 1/6, 1/12, 1/24 etc. af opløsningen Y's koncentration. Til hver af disse opløsninger sættes 1 rumfang Reagens 2 (antiserum) fortyndet til en titer på 20 (se b. ovenfor) og derefter (efter nogle få minutter) 1 rumfang af Reagens 3 (sensibiliserede fåreerythrocyter) , således at der fås slutkoncentrationer af endotoxiner på 1/5, 1/10, 1/20... 1/(5 x 2n”"^) af opløsning Y's. Hæmaggluti-neringen hæmmes i de stærkere endotoxiner-opløsninger men sker i de svagere, og endepunktet for titreringen tages som den op-løsning, hvori hæmagglutineringen lige netop hæmmes. Ved en typisk metode kan dette være ved den sjette opløsning, dvs. en en-dotoxin-koncentration på 1/(5 x 2 ) af opløsning Y's. Opløsning Y siges da at have en titer på 5 x 2^ (= 160), svarende til 160 enheder endotoxin pr. ml (se eksempel 3).The solution (Y) to be measured is serially diluted with 0.15 M NaCl to obtain a series of solutions of equal volume (3 vols) and with endotoxin concentrations of 1/3, 1/6, 1/12, 1/24 etc. of the solution Y's concentration. To each of these solutions, add 1 volume of Reagent 2 (antiserum) diluted to a titer of 20 (see b. Above) and then (after a few minutes) 1 volume of Reagent 3 (sensitized sheep erythrocytes) so that final concentrations of endotoxins are obtained. of solution Y's. Hemagglutination is inhibited in the stronger endotoxins solutions but occurs in the weaker ones and the end point of the titration is taken. as the solution in which the hemagglutination is just inhibited, in a typical method this may be at the sixth solution, i.e., an endotoxin concentration of 1 / (5 x 2) of solution Y's. a titer of 5 x 2 ^ (= 160), corresponding to 160 units of endotoxin per ml (see Example 3).

144083 11144083 11

Eksempel 2.Example 2.

A. Fremstilling af endotoxinmaterlaleA. Preparation of Endotoxin Materials

Den nedenfor anførte metode fulgtes særskilt for hver af de tidligere nævnte E. coli-serotyper.The method described below was followed separately for each of the E. coli serotypes previously mentioned.

(I) Bakterien stryges ud fra en opbevaringskultur på vaskede blodagarplader og inkuberes ved 37°C i 24 timer, hvorefter pladerne kontrolleres på sædvanlig måde for stammens renhed.(I) The bacterium is ironed from a storage culture on washed blood agar plates and incubated at 37 ° C for 24 hours, after which the plates are checked in the usual manner for purity of the strain.

(II) Kolonier af bakterien overføres fra pladerne til 5Q ml Oxoid Nutrient Broth No. 2 (katalog nr. CM 67), og dyrkningsvæsken holdes på 37°C i 24 timer.(II) Colonies of the bacterium are transferred from the plates to 5Q ml of Oxoid Nutrient Broth No. 2 (catalog no. CM 67) and the culture liquid is kept at 37 ° C for 24 hours.

(III) Hele den i (II) opnåede kultur anvendtes til podning af 1,5 liter Oxoid Nutrient Broth No. 2, og dyrkningsvæsken inkuberedes under omrystning ved 37°C i 24 timer.(III) The entire culture obtained in (II) was used to inoculate 1.5 liters of Oxoid Nutrient Broth No. 2, and the culture fluid was incubated with shaking at 37 ° C for 24 hours.

Hver således fremstillet slutkultur indeholdt ca. 101^ levedygtige bakterier pr. ml, og en prøve af kulturen gav, efter dampbehandling ved 125°C i 2 timer og udsættelse for den i eksempel 2 beskrevne prøvemetode, en titer på 2560, svarende til 2560 endotoxin-enheder pr. ml dampbehandlet kultur.Each end culture thus prepared contained ca. Viable bacteria per 100 and a sample of the culture, after steam treatment at 125 ° C for 2 hours and subjected to the test method described in Example 2, gave a titer of 2560, corresponding to 2560 endotoxin units per ml. ml of steam treated culture.

Kulturerne af alle serotyperne samledes sammen, og det samlede produkt dampbehandledes i 2 timer i en autoklav (125°C) til dræbning af bakterierne.The cultures of all the serotypes were pooled and the total product steamed for 2 hours in an autoclave (125 ° C) to kill the bacteria.

B. Fremstilling af svinefoderB. Production of pig feed

Hele den steriliserede dyrkningsvæske opnået som beskrevet under A indstilles på en pH-værdi på 5 og inkorporeres i et vægtforhold på 15:85 i et sædvanligt svineafvænningsfoder af følgende sammensætning: 12 144083 * VægtprocentThe entire sterilized culture fluid obtained as described under A is adjusted to a pH of 5 and incorporated in a weight ratio of 15:85 into a conventional pig wean feed of the following composition: 12%

Valsetørret skummetmælk 20Roll-dried skimmed milk 20

Hvidt fiskemel 25White fish meal 25

Valsede havregryn (havreflager) 36 Sukker (saccharose) 10 Tørret gær (75% uekstraheret) 5,5Rolled oatmeal (oat flakes) 36 Sugar (sucrose) 10 Dried yeast (75% un extracted) 5.5

Torskeleverolie 2Cod liver oil 2

Natriumchlorid 0,5Sodium chloride 0.5

Mineralsk supplement 1,0Mineral supplement 1.0

Det herved fremkomne blandfoder tørres ved 65°C til et fug-tighedsindhold på ca. 15%.The resulting mixed feed is dried at 65 ° C to a moisture content of approx. 15%.

Eksempel 3.Example 3

Den endelige kultur af hver serotype opnået på den under A i eksempel 2 beskrevne måde centrifugeres til fra-skillelse af bakterierne som derefter resuspenderes i vand og opvarmes til 125°C i 30 minutter. De dræbte bakterier behandles derefter i 3 timer ved 37°C med en blanding af enzymerne lysozym og pepsin, og det samlede endotoxinmateriale fra dræbningsbehandlingen og enzymbehandlingen prøves. Det prøvede endotoxin-materiale fra alle serotyperne samles sammen, indstilles på en pH-værdi på 5 og sættes til skummetmælk. Blandingen inkorporeres derefter i et sædvanligt svinefoder af den i eksempel 2 angivne sammensætning, således at der fås en kon- 4 centration på 10 endotoxin-enheder af hver serotype pr. kg foder .The final culture of each serotype obtained in the manner described under A in Example 2 is centrifuged to separate the bacteria which is then resuspended in water and heated to 125 ° C for 30 minutes. The killed bacteria are then treated for 3 hours at 37 ° C with a mixture of the enzymes lysozyme and pepsin, and the total endotoxin material from the killing and enzyme treatment is tested. The endotoxin material tested from all the serotypes is pooled, adjusted to a pH of 5 and added to skim milk. The mixture is then incorporated into a conventional pig feed of the composition set forth in Example 2, so as to obtain a concentration of 10 endotoxin units of each serotype per ml. kg of feed.

DK265771A 1970-06-03 1971-06-01 PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF PIGS DK144083C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2674670 1970-06-03
GB2674670 1970-06-03

Publications (2)

Publication Number Publication Date
DK144083B true DK144083B (en) 1981-12-07
DK144083C DK144083C (en) 1989-11-20

Family

ID=10248578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK265771A DK144083C (en) 1970-06-03 1971-06-01 PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF PIGS

Country Status (13)

Country Link
BE (1) BE768078A (en)
CA (1) CA979806A (en)
DE (1) DE2125641C2 (en)
DK (1) DK144083C (en)
ES (2) ES391698A1 (en)
FR (1) FR2119903B1 (en)
GB (1) GB1336015A (en)
IE (1) IE35321B1 (en)
IT (1) IT1024507B (en)
NL (1) NL7107538A (en)
SE (1) SE421173C (en)
YU (1) YU42918B (en)
ZA (1) ZA713510B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789864A (en) * 1971-10-14 1973-04-09 Unilever Nv CALF BREEDING
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4285931A (en) 1978-01-30 1981-08-25 Merck & Co., Inc. E. coli enterotoxin vaccine for veterinary and human use
FR2466251B1 (en) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech ANTI-COLIBACILLAR VACCINE, OBTAINMENT AND APPLICATION
CH639852A5 (en) * 1979-07-26 1983-12-15 Om Laboratoires Sa MEDICINE AGAINST INFECTIOUS DISEASES OF THE URINARY AND DIGESTIVE PATHWAYS.
WO2008106763A1 (en) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (en) *
CA768129A (en) * 1967-09-26 M. Berger Frank Endotoxin fractions and method for producing same
DE1792256C3 (en) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Orally administered, polyvalent vaccines against local intestinal infections

Also Published As

Publication number Publication date
IT1024507B (en) 1978-07-20
YU42918B (en) 1989-02-28
GB1336015A (en) 1973-11-07
SE421173C (en) 1985-10-28
FR2119903B1 (en) 1974-10-18
BE768078A (en) 1971-12-03
SE421173B (en) 1981-12-07
YU137171A (en) 1982-02-28
ES391698A1 (en) 1975-07-16
CA979806A (en) 1975-12-16
ZA713510B (en) 1973-01-31
IE35321B1 (en) 1976-01-07
NL7107538A (en) 1971-12-07
FR2119903A1 (en) 1972-08-11
DE2125641A1 (en) 1971-12-09
DE2125641C2 (en) 1986-03-13
IE35321L (en) 1971-12-03
DK144083C (en) 1989-11-20
ES417901A1 (en) 1976-06-16

Similar Documents

Publication Publication Date Title
CN101494970B (en) Oral formulation for enteric disorders and/or rehydration
CN1639317B (en) Probiotic lactobacillus salivarius strains
EP2179028B1 (en) A novel strain of bifidobacterium and active peptides against rotavirus infections
WO2020063515A1 (en) Novel application of lactobacillus paracasei k56 capable of regulating balance of gastrointestinal flora
US11911423B2 (en) Bifidobacterium lactis BL-99 and application thereof
CN107075455A (en) Improve Lactobacillus plantarum HAC01 bacterial strains of effect and application thereof with anti-inflammatory and metabolic disease
Tsukahara et al. Probiotic supplementation improves reproductive performance of unvaccinated farmed sows infected with porcine epidemic diarrhea virus
CN101124318A (en) Novel strain conferring anti-disease properties to host and bacterial cell composition
US4141970A (en) Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
DK144083B (en) PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF PIGS
CN117448213B (en) Lactobacillus plantarum for inhibiting clostridium perfringens and its progeny and application
CN108697127A (en) The method of glutelin for the Cereal cereal that detoxifies and its in the application of medical domain
RU2584600C2 (en) L.bulgaricus STRAIN CAPABLE OF INHIBITING ADHESION OF H.pylori STRAINS TO EPITHELIAL CELLS
US3911109A (en) Rearing calves
CN106615622A (en) Feed additive capable of promoting growth of chicks and enhancing capabilities of resisting infection of salmonella pullorum of chicks and application of feed additive
DK144905B (en) PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE PREVENTION OF GASTRO-INTESTINAL DISORDERS OF CALVES
KR101969132B1 (en) Lactobacillus reuteri induced from rat and composition for enhancement of immunity using the same
JPS5839624A (en) Antitumor agent
KR101890351B1 (en) Lactobacillus johnsonii induced from rat and composition for enhancement of immunity using the same
Aiba et al. Role of internalization in the pathogenicity of Shiga toxin‐producing Escherichia coli infection in a gnotobiotic murine model
Alziadi et al. Evaluate the effectiveness of oral dosage with probiotic bacteria lactobacillus rhamnosus GG, lactobacillus planetarium and lactobacillus reuteri on some immune indicators in rabbits
KR20190078864A (en) Novel Salmonella specific bacteriophage SG102 and antibacterial composition comprising the same
RU2735230C1 (en) Method for increasing cicatric digestion in ruminant cattle animals
RU2694256C2 (en) Fodder additive for preventing bacterial carry-over of salmonella microorganisms in agricultural poultry and method for use thereof
KR102129887B1 (en) Novel lactic acid bacteria having antiviral effect and compositions thereof